Natixis’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.36K | Buy |
+40
| New | +$2.36K | ﹤0.01% | 958 |
|
|
2024
Q2 | – | Sell |
-34,996
| Closed | -$1.88M | – | 1041 |
|
|
2024
Q1 | $1.88M | Sell |
34,996
-16,704
| -32% | -$896K | 0.01% | 433 |
|
|
2023
Q4 | $2.76M | Buy |
+51,700
| New | +$2.76M | 0.02% | 347 |
|
|
2022
Q4 | – | Sell |
-106,020
| Closed | -$6.32M | – | 1106 |
|
|
2022
Q3 | $6.32M | Sell |
106,020
-97,300
| -48% | -$5.8M | 0.03% | 351 |
|
|
2022
Q2 | $11.4M | Buy |
+203,320
| New | +$11.4M | 0.04% | 263 |
|
|
2021
Q4 | – | Sell |
-78,400
| Closed | -$6.01M | – | 1283 |
|
|
2021
Q3 | $6.01M | Buy |
78,400
+50,700
| +183% | +$3.88M | 0.02% | 498 |
|
|
2021
Q2 | $2.15M | Buy |
+27,700
| New | +$2.15M | 0.01% | 513 |
|
|
2020
Q2 | – | Sell |
-64,239
| Closed | -$2.73M | – | 789 |
|
|
2020
Q1 | $2.73M | Sell |
64,239
-16,543
| -20% | -$704K | 0.02% | 344 |
|
|
2019
Q4 | $4.75M | Buy |
80,782
+47,936
| +146% | +$2.82M | 0.03% | 414 |
|
|
2019
Q3 | $1.68M | Buy |
+32,846
| New | +$1.68M | 0.01% | 515 |
|
|
2019
Q2 | – | Sell |
-72,449
| Closed | -$3.52M | – | 814 |
|
|
2019
Q1 | $3.52M | Sell |
72,449
-3,861
| -5% | -$188K | 0.02% | 430 |
|
|
2018
Q4 | $3.3M | Buy |
76,310
+9,108
| +14% | +$394K | 0.03% | 379 |
|
|
2018
Q3 | $3.81M | Buy |
67,202
+1,791
| +3% | +$102K | 0.02% | 416 |
|
|
2018
Q2 | $3.3M | Buy |
65,411
+1,970
| +3% | +$99.4K | 0.02% | 438 |
|
|
2018
Q1 | $3.16M | Buy |
63,441
+28,165
| +80% | +$1.4M | 0.02% | 438 |
|
|
2017
Q4 | $1.45M | Buy |
+35,276
| New | +$1.45M | 0.01% | 448 |
|
|
2017
Q3 | – | Sell |
-22,396
| Closed | -$742K | – | 1297 |
|
|
2017
Q2 | $742K | Buy |
22,396
+2,673
| +14% | +$88.6K | 0.01% | 454 |
|
|
2017
Q1 | $584K | Buy |
+19,723
| New | +$584K | 0.01% | 487 |
|